ERS International Congress, Madrid 2019

Browse by day:
Saturday, 28.09.2019
Sunday, 29.09.2019
Monday, 30.09.2019
Tuesday, 01.10.2019
Wednesday, 02.10.2019

 

View the presentations you missed during Congress!

More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

 

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.


Idiopathic pulmonary fibrosis and surroundings

Oral Presentation
Chairs: M. Wijsenbeek (Rotterdam, Netherlands), V. Cottin (Lyon, France)
Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis
A. Nambiar (San Antonio, TX, United States of America), J. Justice (Winston-Salem, NC, United States of America), T. Tchkonia (Rochester, MN, United States of America), N. Lebrasseur (Rochester, MN, United States of America), R. Pascual (Winston-Salem, NC, United States of America), S. Hashmi (Rochester, MN, United States of America), L. Prata (Rochester, MN, United States of America), M. Masternak (Orlando, FL, United States of America), N. Musi (San Antonio, United States of America), S. Kritchevsky (Winston-Salem, NC, United States of America), J. Kirkland (Rochester, MN, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry demonstrates inhaled drug deposition in transbronchial cryobiopsy samples of patients with Interstitial Lung Disease (ILD)
T. Mikolasch (London, United Kingdom), P. Marshall (Stevenage, United Kingdom), E. Oballa (Stevenage, United Kingdom), M. Vahdati-Bolouri (Stevenage, United Kingdom), J. Morell (Stevenage, United Kingdom), E. Jarvis (Stevenage, United Kingdom), Y. Cui (Stevenage, United Kingdom), A. Cahn (Stevenage, United Kingdom), J. Porter (London, United Kingdom)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor
T. Maher (London, United Kingdom), J. Simpson (Stevenage, United Kingdom), J. Porter (London, United Kingdom), R. Chan (Stevenage, United Kingdom), R. Eames (Stevenage, United Kingdom), Y. Cui (Stevenage, United Kingdom), S. Siederer (Stevenage, United Kingdom), S. Parry (Stevenage, United Kingdom), J. Kenny (Stevenage, United Kingdom), R. Slack (London, United Kingdom), R. Marshall (London, United Kingdom), J. Sahota (London, United Kingdom), G. Rizzo (London, United Kingdom), G. Searle (London, United Kingdom), F. Wilson (Stevenage, United Kingdom), A. Saleem (London, United Kingdom), A. Kang'Ombe (Stevenage, United Kingdom), D. Fairman (Stevenage, United Kingdom), W. Fahy (Stevenage, United Kingdom), M. Vahdati-Bolouri (Stevenage, United Kingdom)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Pathological features of lung lesions in PPFE of idiopathic or transplantation related cases with evaluation of the elastic fiber related conditions comparing to those of IPF/UIP
Y. Terasaki (Tokyo, Japan), Y. Kigimoto (Tokyo, Japan), Y. Okabe (Tokyo, Japan), M. Terasaki (Tokyo, Japan), S. Kunugi (Tokyo, Japan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Elevated growth differentiation factor 15 in serum correlated with acute exacerbation of idiopathic pulmonary fibrosis
M. Cao (Nanjing, China), L. Gu (Nanjing, China), J. Lu (Nanjing, China)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey.
A. Tzouvelekis (ATHENS, Greece), K. Antoniou (Crete, Greece), M. Kreuter (Heidelberg, Greece), M. Evison (Manchester, United Kingdom), T. Blum (Berlin, Germany), V. Poletti (Forli, Italy), P. Spagnolo (Padova, Italy), F. Bonella (Essen, Germany), B. Girgoriu (Iasi, Romania), C. Vancheri (Sicily, Italy), J. Cadranel (Paris, France), D. Bouros (Crete, Greece)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry
J. Behr (Munich, Germany), H. Wirtz (Leipzig, Germany), D. Pittrow (Dresden, Germany), A. Prasse (Hannover, Germany), D. Koschel (Coswig, Germany), S. Geier (Ingelheim, Germany), J. Klotsche (Berlin, Germany), S. Andreas (Göttingen, Germany), M. Claussen (Grosshansdorf, Germany), C. Grohé (Berlin, Germany), H. Wilkens (Homburg, Germany), L. Hagmeyer (Solingen, Germany), D. Skowasch (Bonn, Germany), J. Meyer (Munich, Germany), J. Kirschner (Bamberg, Germany), S. Gläser (Greifswald, Germany), N. Kahn (Heidelberg, Germany), T. Welte (Hannover, Germany), C. Neurohr (Gerlingen, Germany), M. Schwaiblmair (Augsburg, Germany), M. Held (Würzburg, Germany), T. Bahmer (Grosshansdorf, Germany), T. Oqueka (Hamburg, Germany), M. Frankenberger (Munich, Germany), M. Kreuter (Heidelberg, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation